Akseli E Hemminki (Akseli Hemminki, A Hemminki)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 59

Top Topics

Radical Prostatectomy

Top Venues

Cancer medicine

International journal of cancer

Clinical epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Kari Hemminki, Frantisek Zitricky, Asta Försti, Akseli E Hemminki
Survival in Elderly Ovarian Cancer Remains Challenging in the Nordic Countries. Cancers 16 (12) (2024)
Santeri A Pakola, Katriina J Peltola, James H A Clubb, Elise Jirovec, Lyna Haybout, Tatiana Viktorovna Kudling, Tuomo Alanko, Riitta Korpisaari, Susanna M Juteau, Marjut Laukka, Jorma Sormunen, Jukka Kemppainen, Annabrita Hemmes, Teijo Pellinen, Mirte van der Heijden, Dafne C A Quixabeira, Claudia Kistler, Suvi Sorsa, Riikka Havunen, Joao M Santos, Victor Cervera-Carrascon, Akseli E Hemminki
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Akseli E Hemminki
Survival in Elderly Ovarian Cancer Remains Challenging in the Nordic Countries. Cancers 16 (12) (2024)
Santeri A Pakola, Katriina J Peltola, James H A Clubb, Elise Jirovec, Lyna Haybout, Tatiana Viktorovna Kudling, Tuomo Alanko, Riitta Korpisaari, Susanna M Juteau, Marjut Laukka, Jorma Sormunen, Jukka Kemppainen, Annabrita Hemmes, Teijo Pellinen, Mirte van der Heijden, Dafne C A Quixabeira, Claudia Kistler, Suvi Sorsa, Riikka Havunen, Joao M Santos, Victor Cervera-Carrascon, Akseli E Hemminki
Safety, efficacy, and biological data of T cell-enabling oncolytic adenovirus TILT-123 in advanced solid cancers from the TUNIMO monotherapy phase I trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients. Cancer medicine 13 (15) (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine 13 (1) (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine (2024)
František Zitrick, Anni Koskinen, Vaclav Liska, Asta Försti, Akseli E Hemminki, Kari Hemminki
Major Improvement in Thyroid Cancer Survival of Elderly Patients in the Nordic Countries. European journal of endocrinology (2024)
Kari Hemminki, Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Otto Hemminki
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis. Cancer medicine 13 (7) (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients. Cancer medicine 13 (15) (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine (2024)
Frantisek Zitricky, Anni I Koskinen, Otto Hemminki, Asta Försti, Akseli E Hemminki, Kari Hemminki
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer medicine (2024)
Kari Hemminki, Frantisek Zitricky, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients. Cancer medicine 13 (15) (2024)
František Zitrický, Anni Koskinen, Vaclav Liska, Asta Försti, Akseli E Hemminki, Kari Hemminki
Major improvement in thyroid cancer survival of elderly patients in the Nordic countries. European journal of endocrinology 190 (3) (2024)
Kari Hemminki, Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Otto Hemminki
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis. Cancer medicine 13 (7) (2024)
Kari Hemminki, Filip Tichanek, Asta Försti, Otto Hemminki, Akseli E Hemminki
Survival in gastric and esophageal cancers in the Nordic countries through a half century. Cancer medicine (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Tatiana V Kudling, James H A Clubb, Santeri Pakola, Dafne C A Quixabeira, Iris A K Lähdeniemi, Camilla Heiniö, Victor Arias, Riikka Havunen, Victor Cervera-Carrascon, Joao M Santos, Eva Sutinen, Jari Räsänen, Kristian Borenius, Mikko I Mäyränpää, Eero Aaltonen, Suvi Sorsa, Otto Hemminki, Anna Kanerva, Emmy W Verschuren, Ilkka Ilonen, Akseli E Hemminki
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer. Oncoimmunology 12 (1) (2023)
Filip Tichánek, Asta Försti, Otto Hemminki, Akseli E Hemminki, Kari Hemminki
Survival in Lung Cancer in the Nordic Countries Through A Half Century. Clinical epidemiology 15 (2023)
Filip Tichanek, Asta Försti, Akseli E Hemminki, Otto Hemminki, Kari Hemminki
Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century. Cancers 15 (10) (2023)
Dafne C A Quixabeira, E Jirovec, Santeri A Pakola, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. Cancer gene therapy (2023)
Filip Tichanek, Asta Försti, Vaclv Liska, Otto Hemminki, Anni Koskinen, Akseli E Hemminki, Kari Hemminki
Early mortality critically impedes improvements in thyroid cancer survival through a half century. European journal of endocrinology 189 (3) (2023)
Elin M V Forsberg, Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Valentina Bucher, Akseli E Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M Nilsson, Henrik Rönnberg, Jonas Andreas Nilsson
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs. Cancers 15 (3) (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Filip Tichánek, Asta Försti, Vaclav Liska, Akseli E Hemminki, Kari Hemminki
Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century. Cancers 15 (3) (2023)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers. Cancers 15 (12) (2023)
Filip Tichánek, Asta Försti, Akseli E Hemminki, Otto Hemminki, Kari Hemminki
Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements. Cancers 15 (17) (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers. Cancers 15 (12) (2023)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer 152 (9) (2023)
Dafne C A Quixabeira, Santeri A Pakola, E Jirovec, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Erja Kerkelä, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. Cancer gene therapy (2023)
Frantisek Zitricky, Asta Försti, Akseli E Hemminki, Otto Hemminki, Kari Hemminki
Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements. Cancers 15 (16) (2023)
Frantisek Zitricky, Asta Försti, Akseli E Hemminki, Kari Hemminki
Conditional survival in breast cancer up to 10 years in the Nordic countries. Cancer medicine (2023)
Filip Tichánek, Asta Försti, Vaclav Liska, Akseli E Hemminki, Kari Hemminki
Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century. Cancers 15 (3) (2023)
Elin M V Forsberg, Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Valentina Bucher, Akseli E Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M Nilsson, Henrik Rönnberg, Jonas Andreas Nilsson
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs. Cancers 15 (3) (2023)
Filip Tichánek, Asta Försti, Otto Hemminki, Akseli E Hemminki, Kari Hemminki
Survival in Lung Cancer in the Nordic Countries Through A Half Century. Clinical epidemiology 15 (2023)
Ilkka Liikanen, Saru Basnet, Dafne C A Quixabeira, Kristian Taipale, Otto Hemminki, Minna Oksanen, Matti Kankainen, Juuso Juhila, Anna Kanerva, Timo Joensuu, Siri Tähtinen, Akseli E Hemminki
Oncolytic adenovirus decreases the proportion of TIM-3 + subset of tumor-infiltrating CD8 + T cells with correlation to improved survival in patients with cancer. Journal for immunotherapy of cancer 10 (2) (2022)
Dafne C A Quixabeira, Victor Cervera-Carrascon, Joao M Santos, James H A Clubb, Tatiana Viktorovna Kudling, Saru Basnet, Camilla Heiniö, Susanna Grönberg-Vähä-Koskela, Marjukka Anttila, Riikka Havunen, Anna Kanerva, Akseli E Hemminki
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1. Oncoimmunology 11 (1) (2022)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country. Cancers 14 (8) (2022)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements. International journal of cancer (2022)
Kari Hemminki, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast. International journal of cancer 151 (2) (2022)
Kari Hemminki, Asta Försti, Vaclav Liska, Anna Kanerva, Otto Hemminki, Akseli E Hemminki
LONG-TERM SURVIVAL TRENDS IN SOLID CANCERS IN THE NORDIC COUNTRIES MARKING TIMING OF IMPROVEMENTS. International journal of cancer (2022)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Vaclav Liska, Akseli E Hemminki, Xinjun Li
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers. International journal of cancer (2022)
Tatiana V Kudling, James H A Clubb, Dafne C A Quixabeira, Joao M Santos, Riikka Havunen, Alexander Kononov, Camilla Heiniö, Victor Cervera-Carrascon, Santeri Pakola, Saru Basnet, Susanna Grönberg-Vähä-Koskela, Victor Arias, Ivan Gladwyn-Ng, Katri Aro, Leif Bäck, Jari Räsänen, Ilkka Ilonen, Kristian Borenius, Mikko Räsänen, Otto Hemminki, Antti Rannikko, Anna Kanerva, Johanna Tapper, Akseli E Hemminki
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression. Oncoimmunology 11 (1) (2022)
Kari Hemminki, Filip Tichanek, Asta Försti, Otto Hemminki, Vaclav Liska, Akseli E Hemminki
Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast? International journal of cancer 151 (4) (2022)
Camilla Heiniö, James Clubb, Tatiana Viktorovna Kudling, Dafne C A Quixabeira, Victor Cervera-Carrascon, Riikka Havunen, Susanna Grönberg-Vähä-Koskela, João Manuel Santos, Johanna Tapper, Anna Kanerva, Akseli E Hemminki
Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers. Diseases (Basel, Switzerland) 10 (3) (2022)
Joao Santos, Camilla Heiniö, Dafne C A Quixabeira, Sadia Zafar, James Clubb, Santeri Pakola, Victor Cervera-Carrascon, Riikka Havunen, Anna Kanerva, Akseli E Hemminki
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers. Cells 10 (5) (2021)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Tianhui Chen, Asta Försti, Akseli E Hemminki, Vaclav Liska, Kari Hemminki
Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers. Clinical epidemiology 13 (2021)
Kari Hemminki, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Xinjun Li
Familial Risks and Proportions Describing Population Landscape of Familial Cancer. Cancers 13 (17) (2021)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Tianhui Chen, Asta Försti, Akseli E Hemminki, Kari Hemminki
Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer. Clinical epidemiology 13 (2021)
Sadia Zafar, Dafne Carolina Alves Quixabeira, Tatiana Viktorovna Kudling, Victor Cervera-Carrascon, Joao Manuel Santos, Susanna Grönberg-Vähä-Koskela, Fang Zhao, Pasi Aronen, Camilla Heiniö, Riikka Havunen, Suvi Sorsa, Anna Kanerva, Akseli E Hemminki
Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes. Cancer gene therapy 28 (5) (2020)
João Manuel Santos, Camilla Heiniö, Victor Cervera-Carrascon, Dafne C A Quixabeira, Mikko Siurala, Riikka Havunen, Ralf Butzow, Sadia Zafar, Tanja de Gruijl, Heini Lassus, Anna Kanerva, Akseli E Hemminki
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity. Journal for immunotherapy of cancer 8 (1) (2020)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Kari Hemminki
Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues. Clinical epidemiology 12 (2020)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli E Hemminki, Kari Hemminki
Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor. Cancer medicine 9 (21) (2020)
Subhayan Chattopadhyay, Guoqiao Zheng, Amit Sud, Kristina Sundquist, Jan Sundquist, Asta Försti, Richard Houlston, Akseli E Hemminki, Kari Hemminki
Second primary cancers in non-Hodgkin lymphoma: Family history and survival. International journal of cancer 146 (4) (2019)
Subhayan Chattopadhyay, Amit Sud, Guoqiao Zheng, Hongyao Yu, Kristina Sundquist, Jan Sundquist, Asta Försti, Richard Houlston, Akseli E Hemminki, Kari Hemminki
Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction. International journal of cancer 143 (10) (2018)
Guoqiao Zheng, Akseli E Hemminki, Asta Försti, Jan Sundquist, Kristina Sundquist, Kari Hemminki
Second primary cancer after female breast cancer: Familial risks and cause of death. Cancer medicine 8 (1) (2018)
Joao Manuel Santos, Riikka Havunen, Mikko Siurala, Víctor Cervera-Carrascon, Siri Tähtinen, Suvi Sorsa, Marjukka Anttila, Pauliina Karell, Anna Kanerva, Akseli E Hemminki
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy. International journal of cancer 141 (7) (2017)
Guoqiao Zheng, Hongyao Yu, Akseli E Hemminki, Asta Försti, Kristina Sundquist, Kari Hemminki
Familial associations of female breast cancer with other cancers. International journal of cancer 141 (11) (2017)